Poudel Bibek, Yadav Binod Kumar, Nepal Ashwini Kumar, Jha Bharat, Raut Kanak Bahadur
Department of Biochemsitry, Manipal College of Medical Sciences, Pokhara, Nepal.
N Am J Med Sci. 2012 Aug;4(8):331-5. doi: 10.4103/1947-2714.99501.
Microalbuminuria in hypertension has been described as an early sign of kidney damage and a predictor for end stage renal disease and cardiovascular disease. Thus, it is of great importance to study urinary albumin creatinine ratio and progression of kidney disease in hypertensive patients.
The present study was undertaken to find out the prevalence and association of microalbuminuria in newly diagnosed essential hypertension.
Newly diagnosed essential hypertensive cases (n = 106) and normotensive controls (n = 106) were enrolled. Hypertension was defined according to Joint national committee-VII definitions. Microalbuminuria was measured using an U-Albumin (NycoCard, Norway) and adjusted for urine creatinine. Descriptive statistics and testing of hypothesis were used for the analysis using SPSS 16 software.
51.88% of hypertension cases and 13.2% of normotensive controls had microalbuminuria in total population (odds ratio 7.086, P-value <0.001). 46.67% of cases and 12.08% of controls had microalbuminuria in male population (odds ratio 6.375, P-value <0.001). Similarly, 58.7% of cases and 14.58% of controls had microalbuminuria in female population (odds ratio 8.32, P-value <0.001).
By showing strong association between microalbuminuria and hypertension, our findings suggest that microalbuminuria could be a useful marker to assess risk management of cardiovascular disease and renal disease.
高血压患者的微量白蛋白尿被认为是肾脏损害的早期迹象,也是终末期肾病和心血管疾病的预测指标。因此,研究高血压患者的尿白蛋白肌酐比值及肾脏疾病进展具有重要意义。
本研究旨在探讨新诊断的原发性高血压患者中微量白蛋白尿的患病率及其相关性。
纳入新诊断的原发性高血压患者106例及血压正常对照者106例。高血压的定义依据美国国家联合委员会第七版标准。采用U-白蛋白(挪威NycoCard)检测微量白蛋白尿,并根据尿肌酐进行校正。使用SPSS 16软件进行描述性统计和假设检验分析。
在总体人群中,51.88%的高血压患者和13.2%的血压正常对照者存在微量白蛋白尿(优势比7.086,P值<0.001)。男性人群中,46.67%的患者和12.08%的对照者存在微量白蛋白尿(优势比6.375,P值<0.001)。同样,女性人群中,58.7%的患者和14.58%的对照者存在微量白蛋白尿(优势比8.32,P值<0.001)。
通过显示微量白蛋白尿与高血压之间的强相关性,我们的研究结果表明微量白蛋白尿可能是评估心血管疾病和肾脏疾病风险管理的有用标志物。